A 45-year-old man presents with acute monoarthritis of the first metatarsophalangeal joint. Joint aspirate demonstrates needle-shaped, negatively birefringent crystals. Serum urate is elevated. According to Australian gout management principles, what is the most appropriate long-term target serum urate level for urate-lowering therapy?